PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France; INSERM U-1018, CESP, Epidémiologie clinique, UVSQ, Université de Paris Saclay, Villejuif, France.\', \'Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France.\', \'Handiresp EA 4047, UFR Simone-Veil-Santé, Université de Versailles St-Quentin, Montigny le Bretonneux, Garches, France; Département Hospitalier d\'Epidémiologie et de Santé Publique, AP-HP, GHU Paris Saclay, Hôpital Raymond-Poincaré, Garches, France.\', \'Clinical Research Unit AP-HP Paris-Saclay, School of Medicine Simone Veil, UVSQ - University Paris Saclay, INSERM, CESP Anti-Infective Evasion and Pharmacoepidemiology Team, Montigny-Le-Bretonneux, France.\', \'Department of Critical Care, Raymond Poincaré Hospital (AP-HP), Laboratory Infection and Inflammation, U1173, Faculty of Health Science Simone Veil, University of Versailles SQY, University Paris Saclay, INSERM, FHU SEPSIS, RHU RECORDS, Versailles, France.\', \'Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne-Billancourt, France; INSERM U-1018, CESP, Epidémiologie clinique, UVSQ, Université de Paris Saclay, Villejuif, France. Electronic address: nicolas.mansencal@aphp.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0002-9149(21)00153-310.1016/j.amjcard.2021.02.009
?:doi
?:hasPublicationType
?:journal
  • The American journal of cardiology
is ?:pmid of
?:pmid
?:pmid
  • 33617818
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33617818>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33617818>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all